News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, Tax Shelters, Insurance bonds. Healthy returns: Japan’s assault on old-age di ...

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

Today, BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) held its Annual General Meeting in Stockholm today, whereby the following resolutions were made. Adoption of the income statement ...

Eli Lilly (NYSE:LLY) has received regulatory approval to market its Alzheimer’s therapy Kisunla (donanemab) in Australia, ...

The test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s ...

China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most ...

The test potentially makes it easier to find and treat patients with the memory-robbing disease. Read more at straitstimes.com. Read more at straitstimes.com.

A dementia-focused transatlantic venture capital initiative has secured $269 million in commitments for its second fund. | A dementia-focused transatlantic venture capital initiative has secured $269 ...

The FDA cleared the test for early detection of amyloid plaques associated with Alzheimer’s in people aged 55 years and older ...

U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...

The Food and Drug Administration (FDA) has cleared Lumipulse G for U.S. commercialization as the first blood-based test that could help in the diagnosis of Alzheimer’s disease. Developed by ...